Arantza Sanvisens

Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study

Laura Botta, Gemma Gatta, Riccardo Capocaccia et al. · The Lancet Oncology · 2022 · 167 citations · Full text

Cure Fraction Estimates, Cancer Epidemiology, Childhood Cancer +9

Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study

Roberta De Angelis, Elena Demuru, Paolo Baili et al. · The Lancet Oncology · 2024 · 95 citations · Full text

Disease Duration, Epidemiology, Population-based Study +13

Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

Sergio Serrano‐Villar, Javier Martínez‐Sanz, Raquel Ron et al. · The Lancet HIV · 2020 · 68 citations · Full text

Primary Immunodeficiency, Treatment And Prevention, Human Retrovirus +9

Acute coronary syndrome and cocaine use: 8-year prevalence and inhospital outcomes

Xavier Carrillo, Antonio Curós, Roberto Muga et al. · European Heart Journal · 2011 · 58 citations · Full text

Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 1987–2001

Roberto Muga, Arantza Sanvisens, Ferrán Bolao et al. · Drug and Alcohol Dependence · 2006 · 47 citations

Injection Drug Users, Treatment And Prevention, Viral Hepatitis +7